A confirmed first-line option for CLL

被引:0
|
作者
Rebecca Kirk
机构
关键词
D O I
10.1038/nrclinonc.2011.38
中图分类号
学科分类号
摘要
引用
收藏
页码:253 / 253
相关论文
共 50 条
  • [41] Fludarabine, cyclophosphamide and rituximab (FCR) first-line therapy in CLL patients: an analysis of the registry of the German CLL Study Group
    Fink, A. M.
    Federhen, A.
    Kutsch, N.
    Stumpf, J.
    Giza, A.
    Robrecht, S.
    Stoltefuss, A.
    Vehling-Kaiser, U.
    Koenigsmann, M.
    Tausch, E.
    Schneider, C.
    Stilgenbauer, S.
    Illmer, T.
    Schlag, R.
    Doerfel, S.
    Gaska, T.
    Kiehl, M.
    Fischer, K.
    Eichhorst, B.
    Hallek, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 119 - 120
  • [42] First line therapy of CLL
    Hallek, Michael
    HEMATOLOGICAL ONCOLOGY, 2023, 41 : 129 - 135
  • [43] SINGLE AGENT RITUXIMAB IS A VALID OPTION FOR FIRST-LINE TREATMENT IN FOLLICULAR LYMPHOMA
    Ghielmini, M.
    ANNALS OF ONCOLOGY, 2011, 22 : 81 - 81
  • [44] Necitumumab: a new option for first-line treatment of squamous cell lung cancer
    Jimenez Aguilar, Elizabeth
    Zugazagoitia Fraile, Jon
    Paz-Ares Rodriguez, Luis
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (08) : 765 - 772
  • [47] Platelet-rich fibrin is the first-line treatment option for periodontal regeneration
    Su, Ni-Yu
    Yang, Li-Chiu
    Chang, Yu-Chao
    JOURNAL OF DENTAL SCIENCES, 2017, 12 (03) : 203 - 204
  • [49] Ketamine is a good first-line option for severely agitated patients in the prehospital environment
    Miner, James R.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2018, 36 (03): : 501 - 502
  • [50] Stereotactic radiofrequency ablation as a valid first-line treatment option for hepatocellular adenomas
    Laimer, Gregor
    Schullian, Peter
    Scharll, Yannick
    Putzer, Daniel
    Eberle, Gernot
    Oberhuber, Georg
    Bale, Reto
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2022, 39 (01) : 780 - 787